Risk stratification for sudden cardiac death in hypertrophic cardiomyopathy: systematic review of clinical risk markers.
about
Risk stratification at diagnosis for children with hypertrophic cardiomyopathy: an analysis of data from the Pediatric Cardiomyopathy Registry.Prevalence of HCM and long QT syndrome mutations in young sudden cardiac death-related cases.Fragmented QRS as a predictor of arrhythmic events in patients with hypertrophic obstructive cardiomyopathy.Heart rate recovery in patients with hypertrophic cardiomyopathy.Female sex is associated with worse prognosis in patients with hypertrophic cardiomyopathy in China.Strategies for the prevention and treatment of sudden cardiac death.Surface fragmented QRS in a patient with hypertrophic cardiomyopathy and malignant arrhythmias: Is there an association?Cardiac MRI evaluation of hypertrophic cardiomyopathy: left ventricular outflow tract/aortic valve diameter ratio predicts severity of LVOT obstructionThe role of renin-angiotensin-aldosterone system polymorphisms in phenotypic expression of MYBPC3-related hypertrophic cardiomyopathyAlmanac 2011: cardiomyopathies. The national society journals present selected research that has driven recent advances in clinical cardiology.Systematic review of pregnancy in women with inherited cardiomyopathies.Genetic testing for inherited cardiac disease.Almanac 2014: cardiomyopathies.Prevention of sudden death in hypertrophic cardiomyopathy: bridging the gaps in knowledge.Rapid Device-Detected Nonsustained Ventricular Tachycardia in the Risk Stratification of Hypertrophic Cardiomyopathy.Genetics and Genomics of Single-Gene Cardiovascular Diseases: Common Hereditary Cardiomyopathies as Prototypes of Single-Gene Disorders.Appropriate Implantable Defibrillator Therapy in Adults With Hypertrophic Cardiomyopathy.Improved robust T-wave alternans detectors.Genotype-phenotype Correlations of Hypertrophic Cardiomyopathy When Diagnosed in Children, Adolescents, and Young Adults.LEOPARD Syndrome Caused by Tyr279Cys Mutation in the PTPN11 Gene.Hypertrophic Cardiomyopathy: Genetics, Pathogenesis, Clinical Manifestations, Diagnosis, and Therapy.Risk assessment in hypertrophic cardiomyopathy: contemporary guidelines hampered by insufficient evidence.Sudden cardiac arrest in a young patient with hypertrophic cardiomyopathy and zero canonical risk factors: the inherent limitations of risk stratification in hypertrophic cardiomyopathy.Predictors of risk for sudden death in childhood hypertrophic cardiomyopathy: the importance of the ECG risk score.Holter monitoring and long-term prognosis in hypertrophic cardiomyopathy.Abnormal sodium channel mRNA splicing in hypertrophic cardiomyopathy.Mid-term outcomes of biventricular obstruction and left ventricular outflow tract obstruction after surgery correction in child and adolescent patients with hypertrophic cardiomyopathy.Ventricular arrhythmia and sudden cardiac death in Fabry disease: a systematic review of risk factors in clinical practice.Distinct ECG Phenotypes Identified in Hypertrophic Cardiomyopathy Using Machine Learning Associate With Arrhythmic Risk Markers.Prognostic value of cardiovascular magnetic resonance imaging for life-threatening arrhythmia detected by implantable cardioverter-defibrillator in Japanese patients with hypertrophic cardiomyopathy.Hypertrophic cardiomyopathy: Sudden cardiac death risk stratification in adults
P2860
Q30665383-325DA2EB-84D8-48EF-B353-389B411C3740Q33159946-39998AD4-7D46-4798-B503-18A484900640Q33163246-ACFFBA09-66FD-4040-986F-A7A7DC721F78Q33687654-E9D97FB5-0EEC-49F0-9419-0C198E71CA87Q33927715-203364F2-1D90-4CBB-966E-C91622428077Q35560103-35289A9D-9E54-48FC-8697-E376A7E0DC9AQ35733451-8208268F-BCB1-4B29-822B-B400FCDCF807Q36140098-3D05B659-2E9C-40A9-B433-66542C9ACA4BQ36253420-0A08C02C-B9BA-4E50-8049-B301E867DA67Q36587026-43BE6A2F-756C-444D-83EE-4A81D3DF6933Q37863951-C680A6E0-F9F4-428A-9E88-36DFB83C179DQ38125385-56F604EE-2765-4801-A7D0-5D819FADBC99Q38193960-9E7816BE-4D90-4DD5-A5DC-FD10742256FCQ38884022-6A012FAB-BE63-44E9-BA80-911EB28BC599Q38888427-B6A7644A-EA85-41A6-AED4-91A42BE108E6Q39050554-E409696F-7D34-4C21-B438-9A5F9C04F72FQ39801126-513010D9-624B-4D57-B003-3E08A28EB226Q41491729-119BAF98-27A1-4439-87D1-4B854B23265AQ41681436-27D4628B-D758-4D27-B2E9-036D7C1793FEQ42180234-70B859B8-0738-403B-979E-F2685A15D38EQ42515078-9B1FEE17-8168-446A-9699-1E9AC7D4D5C5Q43217399-0FDD7182-7B34-4CE1-970E-13DF4E8EE418Q45537991-57AECAF6-0459-4415-B091-B7C39B72D64FQ47134714-CC1BF3A5-85B1-410A-8170-A9195CD96E2DQ47591461-2055EB65-24F1-4397-8CB8-D455BA548EB9Q47794323-9E2191A7-9B86-40EA-96D3-AB494ABDB7C3Q48505388-0BD93530-93B8-4346-BB2B-9627A2139E6FQ50089735-B0C2488C-2C5B-4FB9-A0AA-7307CEDE993EQ51730904-03CCBD46-1E1F-4271-BA4E-BCA6D1A8351EQ54164038-04C9351D-508F-4823-9E95-D7425118302BQ58565579-D8DD9B90-7ED9-41FD-95A1-5AB4EFCFDDE4
P2860
Risk stratification for sudden cardiac death in hypertrophic cardiomyopathy: systematic review of clinical risk markers.
description
2010 nî lūn-bûn
@nan
2010 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Risk stratification for sudden ...... view of clinical risk markers.
@ast
Risk stratification for sudden ...... view of clinical risk markers.
@en
type
label
Risk stratification for sudden ...... view of clinical risk markers.
@ast
Risk stratification for sudden ...... view of clinical risk markers.
@en
prefLabel
Risk stratification for sudden ...... view of clinical risk markers.
@ast
Risk stratification for sudden ...... view of clinical risk markers.
@en
P2093
P2860
P356
P1433
P1476
Risk stratification for sudden ...... view of clinical risk markers.
@en
P2093
Erwin Birnie
Gouke J Bonsel
Imke Christiaans
Irene M van Langen
Klaartje van Engelen
Perry M Elliott
P2860
P304
P356
10.1093/EUROPACE/EUP431
P577
2010-01-29T00:00:00Z